| Tira Elizabeth Nesset, FNP | |
|
5555 Ne Elam Young Pkwy, Hillsboro, OR 97124-6452 | |
| (503) 216-1600 | |
| Not Available |
| Full Name | Tira Elizabeth Nesset |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 5555 Ne Elam Young Pkwy, Hillsboro, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245617158 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 201502429NP-PP (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
79 million American adults have prediabetes and will likely develop diabetes later in life, according to the Centers for Disease Control and Prevention. As the number of people diagnosed with diabetes continues to grow, researchers are focusing on discovering why the prevalence of the disease is increasing.
Alchemia Limited, today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC). Two patients have received their first doses of therapy. This investigator sponsored trial is being conducted at Monash Cancer Centre, Southern Health and Peninsula Oncology Centre in Melbourne, Victoria.
Researchers in the United States have conducted a study showing that while variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can compromise the effectiveness of single therapeutic antibodies at preventing severe coronavirus disease 2019 (COVID-19), many combination antibody products remain potent against the variants.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
79 million American adults have prediabetes and will likely develop diabetes later in life, according to the Centers for Disease Control and Prevention. As the number of people diagnosed with diabetes continues to grow, researchers are focusing on discovering why the prevalence of the disease is increasing.
Alchemia Limited, today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC). Two patients have received their first doses of therapy. This investigator sponsored trial is being conducted at Monash Cancer Centre, Southern Health and Peninsula Oncology Centre in Melbourne, Victoria.
Researchers in the United States have conducted a study showing that while variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can compromise the effectiveness of single therapeutic antibodies at preventing severe coronavirus disease 2019 (COVID-19), many combination antibody products remain potent against the variants.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tira Elizabeth Nesset, FNP Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Tira Elizabeth Nesset, FNP 5555 Ne Elam Young Pkwy, Hillsboro, OR 97124-6452 Ph: (503) 216-1600 |
News Archive
79 million American adults have prediabetes and will likely develop diabetes later in life, according to the Centers for Disease Control and Prevention. As the number of people diagnosed with diabetes continues to grow, researchers are focusing on discovering why the prevalence of the disease is increasing.
Alchemia Limited, today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC). Two patients have received their first doses of therapy. This investigator sponsored trial is being conducted at Monash Cancer Centre, Southern Health and Peninsula Oncology Centre in Melbourne, Victoria.
Researchers in the United States have conducted a study showing that while variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can compromise the effectiveness of single therapeutic antibodies at preventing severe coronavirus disease 2019 (COVID-19), many combination antibody products remain potent against the variants.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.
› Verified 2 days ago
Tina M Barber, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 19075 Nw Tanasbourne Dr, Suit 200, Hillsboro, OR 97124 Phone: 503-684-8252 | |
Timothy Charles Kruth, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10690 Ne Cornell Rd Ste 220, Hillsboro, OR 97124 Phone: 503-848-5861 Fax: 503-848-5863 | |
Ms. Kathryn Rose Van Beeck, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 19400 Nw Evergreen Pwy, Hillsboro, OR 97124 Phone: 503-645-2762 | |
Shannon Hummel, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 535 Se Washington St, Hillsboro, OR 97123 Phone: 503-755-6703 Fax: 503-755-6704 | |
Margaret Wittenauer-lee, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 333 Se 7th Ave Suite 5550, Hillsboro, OR 97123 Phone: 503-681-4273 | |
Patricia Hazel Glazier, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4660 Ne Belknap Ct, Suite 109, Hillsboro, OR 97124 Phone: 503-693-1944 Fax: 503-693-1941 | |
Erin Whitney Kilgannon Schmidt, DNP CPNP - AC/PC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 445 E Main St, Hillsboro, OR 97123 Phone: 503-640-2757 |